文献速递认知障碍与痴呆

阿尔茨海默病的生物学亚型:系统综述与荟萃分析

Biological subtypes of Alzheimer disease: A systematic review and meta-analysis.
PubMed 文献 · Neurology · 2020-02-11

该研究基于尸检和神经影像学数据,对阿尔茨海默病(AD)亚型研究进行了系统综述与荟萃分析,检索至2019年7月。结果一致识别出典型型、边缘系统为主型、海马保留型3种亚型,另有少数研究识别出轻微萎缩型;各亚型在起病年龄、性别、受教育年限、APOE ε4及脑脊液标志物等方面存在差异。作者提出典型性与严重度两个异质性核心维度,可与A/T/N分类方案结合使用。

要点

  • AD可按tau病理与脑萎缩分布分为典型型、边缘系统为主型、海马保留型及轻微萎缩型。
  • 各亚型在起病年龄、认知状态、APOE ε4和脑脊液标志物等方面存在差异。
  • 亚型模型可与A/T/N分类结合,服务于精准医学与药物研发。

核心结论

  • AD存在基于tau相关病理和区域脑萎缩分布的 distinct 亚型,异质性可归纳为典型性与严重度两个核心维度。

研究设计与样本

  • 系统综述与荟萃分析,检索EMBASE、PubMed和Web of Science数据库至2019年7月,纳入基于尸检和神经影像数据的AD亚型研究。

主要发现

  • 神经病理和神经影像研究一致识别出典型型、边缘系统为主型和海马保留型3种AD亚型。
  • 典型AD在海马和联合皮质均显示tau相关病理和萎缩,合并频率为55%。
  • 边缘系统为主型、海马保留型和轻微萎缩型的合并频率分别为21%、17%和15%。
  • 亚型间在起病年龄、评估年龄、性别分布、受教育年限、整体认知状态、病程、APOE ε4基因型和脑脊液生物标志物水平上存在差异。

临床怎么用

  • 可依据tau病理与萎缩分布将AD患者归入不同亚型,并结合A/T/N分类方案辅助研究设计与结果解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To test the hypothesis that distinct subtypes of Alzheimer disease (AD) exist and underlie the heterogeneity within AD, we conducted a systematic review and meta-analysis on AD subtype studies based on postmortem and neuroimaging data. METHODS: EMBASE, PubMed, and Web of Science databases were consulted until July 2019. RESULTS: Neuropathology and neuroimaging studies have consistently identified 3 subtypes of AD based on the distribution of tau-related pathology and regional brain atrophy: typical, limbic-predominant, and hippocampal-sparing AD. A fourth subtype, minimal atrophy AD, has been identified in several neuroimaging studies. Typical AD displays tau-related pathology and atrophy both in hippocampus and association cortex and has a pooled frequency of 55%. Limbic-predominant, hippocampal-sparing, and minimal atrophy AD had a pooled frequency of 21%, 17%, and 15%, respectively. Between-subtype differences were found in age at onset, age at assessment, sex distribution, years of education, global cognitive status, disease duration, APOE ε4 genotype, and CSF biomarker levels. CONCLUSION: We identified 2 core dimensions of heterogeneity: typicality and severity. We propose that these 2 dimensions determine individuals' belonging to one of the AD subtypes based on the combination of protective factors, risk factors, and concomitant non-AD brain pathologies. This model is envisioned to aid with framing hypotheses, study design, interpretation of results, and understanding mechanisms in future subtype studies. Our model can be used along the A/T/N classification scheme for AD biomarkers. Unraveling the heterogeneity within AD is critical for implementing precision medicine approaches and for ultimately developing successful disease-modifying drugs for AD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Ferreira D, Nordberg A, Westman E, et al. Biological subtypes of Alzheimer disease: A systematic review and meta-analysis. Neurology. 2020. PMID: 32047067. doi:10.1212/WNL.0000000000009058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。